VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ASCO 2015 | Design and results of PERSIST-1 trial of pacritinib for myelofibrosis

Dr Ruben A. Mesa discusses the design and results of the phase 3 PERSIST- trial of pacritinib for patients with myelofibrosis.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter